Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics) - Image 1

£49.90

Springer Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Name: Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
Brand: Springer
Price: 49.9 GBP
Availability: InStock

Sd-bo02

Pharmacy - Dispensing

Price History & Forecast

Last 25 days • 25 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 25 days • 1 price levels

Days at Price

Price Analysis

Most common price: £50 (25 days, 100.0%)

Price range: £50 - £50

Price levels: 1 different prices over 25 days

Description

This book focuses on important decision points and evidence needed for making decisions at these points during the development of a new drug. It takes a holistic approach towards drug development by incorporating explicitly knowledge learned from the earlier part of the development and available historical information into decisions at later stages. In addition, the book shares lessons learned from several select examples published in the literature since the publication of the first edition. The second edition reiterates the need for making evidence-based Go/No Go decisions in drug development discussed in the first edition. It substantially expands several topics that have seen great advances since the publication of the first edition. The most noticeable additions include three adaptive trials conducted in recent years that offer excellent learning opportunities, the use of historical data in the design and analysis of clinical trials, and extending decision criteria tothe cases when the primary endpoint is binary. The examples used to illustrate the additional materials all come from real trials with some post-trial reflections offered by the authors. The book begins with an overview of product development and regulatory approval pathways. It then discusses how to incorporate prior knowledge into study design and decision making at different stages of drug development. Prior knowledge includes information pertaining to historical controls. To assist decision making, the book discusses appropriate metrics and the formulation of go/no-go decisions for progressing a drug candidate to the next development stage. Using the concept of the positive predictive value in the field of diagnostics, the book leads readers to the assessment of the probability that an investigational product is effective given positive study outcomes. Lastly, the book points out common mistakes made by drug developers under the current drug-development paradigm. The book offers useful insights to statisticians, clinicians, regulatory affairs managers and decision-makers in the pharmaceutical industry who have a basic understanding of the drug-development process and the clinical trials conducted to support drug-marketing authorization. The authors provide software codes for select analytical approaches discussed in the book. The book includes enough technical details to allow statisticians to replicate the quantitative illustrations so that they can generate information to facilitate decision-making themselves.

Product Specifications

Brand: Springer
Colour: Sd-bo02
Size: 8' X 10'
Format: paperback
ASIN: 3030797333
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 05 September 2022
Listed Since: 08 August 2022

Barcode

No barcode data available

Springer Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

New Drug Development: An Introduction to Clinical Trials: Second Edition

New Drug Development: An Introduction to Clinical Trials: Second Edition

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Handbook of Adaptive Designs in Pharmaceutical and Clinical Development

Dose Finding in Drug Development (Statistics for Biology and Health)

Statistical Methods in Biomarker and Early Clinical Development

Statistical Methods in Biomarker and Early Clinical Development

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials (Springer Series in Pharmaceutical Statistics)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Practical Considerations for Adaptive Trial Design and Implementation (Statistics for Biology and Health)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Development and Evaluation of Drugs: From Laboratory through Licensure to Market

Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials (Springer Series in Pharmaceutical Statistics)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Nonclinical Statistics for Pharmaceutical and Biotechnology Industries (Statistics for Biology and Health)

Fundamentals of Drug Development

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

CRC Press Clinical Drug Trials and Tribulations - Revised Edition